Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Genertec Universal Medical Group CoFRA:5UM -0.41%48 Cyclically Adjusted PS Ratio is 0.85 as of Aug. 21, 2026, which is 22% below its 10-year median of 1.09. GuruFocus rates FRA:5UM with a GF Score™ of 48/100 and a GF Value™ of €0.48 (Fairly Valued). The stock has 5 warning signs investors should review. Among 420 Credit Services companies, Genertec Universal Medical Group Co ranks better than 81.19% on this metric.
The historical rank and industry rank for Genertec Universal Medical Group Co's Cyclically Adjusted PS Ratio or its related term are showing as below:
FRA:5UM'
s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 0.81 Med: 1.09 Max: 1.36
Current: 0.85
During the past 12 years, Genertec Universal Medical Group Co's highest Cyclically Adjusted PS Ratio was 1.36. The lowest was 0.81. And the median was 1.09.
FRA:5UM's Cyclically Adjusted PS Ratio is ranked better than 81.19% of 420
companies
in the Credit Services industry
Industry Median: 3.03
vs FRA:5UM: 0.85
The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.
Genertec Universal Medical Group Co's adjusted revenue per share data of for the fiscal year that ended in Dec25 was €0.900. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is €0.57 for the trailing ten years ended in Dec25.
Shiller PE for Stocks: The True Measure of Stock Valuation
Genertec Universal Medical Group Co (FRA:5UM) Cyclically Adjusted PS Ratio Explanation
Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.
If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.
Genertec Universal Medical Group Co Cyclically Adjusted PS Ratio Related Terms
Genertec Universal Medical Group Co Cyclically Adjusted PS Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Genertec Universal Medical Group Co Cyclically Adjusted PS Ratio Chart
FRA:5UM vs V, MA, AXP: Cyclically Adjusted PS Ratio Comparison
For the Credit Services subindustry, Genertec Universal Medical Group Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Genertec Universal Medical Group Co Cyclically Adjusted PS Ratio vs Credit Services Industry
For the Credit Services industry and Financial Services sector, Genertec Universal Medical Group Co's Cyclically Adjusted PS Ratio distribution charts can be found below:
* The bar in red indicates where Genertec Universal Medical Group Co's Cyclically Adjusted PS Ratio falls into.
Genertec Universal Medical Group Co Cyclically Adjusted PS Ratio Calculation
Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.
The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.
What does a Cyclically Adjusted PS Ratio of 0.85 mean?
Genertec Universal Medical Group Co (FRA:5UM) has a Cyclically Adjusted PS Ratio of 0.85 as of Aug. 21, 2026. Cyclically Adjusted PS Ratio is the ratio of share price to a company's inflation-adjusted revenue per share over a 10-year period. View historical data on Genertec Universal Medical Group Co and its competitors. This is 22% below median its historical median of 1.09. Over the past decade, Genertec Universal Medical Group Co's Cyclically Adjusted PS Ratio has ranged from 0.81 to 1.36. According to the industry distribution chart, Genertec Universal Medical Group Co ranks #79 out of 420 companies in the Credit Services industry, placing it in the top 18.8%.
Is Genertec Universal Medical Group Co's Cyclically Adjusted PS Ratio too high?
Genertec Universal Medical Group Co's current Cyclically Adjusted PS Ratio of 0.85 is 22% below median its 10-year median of 1.09. Over the past 10 years, this metric has ranged from a low of 0.81 to a high of 1.36. The Credit Services industry median Cyclically Adjusted PS Ratio is 3.03. Genertec Universal Medical Group Co's value of 0.85 is 71.9% below this industry median. Based on the distribution chart, Genertec Universal Medical Group Co ranks #79 out of 420 companies in the Credit Services industry, which is in the top quartile — a strong position relative to peers. Overall, Genertec Universal Medical Group Co has a GF Score™ of 48/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Genertec Universal Medical Group Co's Cyclically Adjusted PS Ratio compare to V and MA?
According to the Credit Services industry distribution chart, Genertec Universal Medical Group Co ranks #79 out of 420 companies for Cyclically Adjusted PS Ratio. This places Genertec Universal Medical Group Co in the top 19% of its industry — outperforming the majority of peers. The industry median Cyclically Adjusted PS Ratio is 3.03. Genertec Universal Medical Group Co's value of 0.85 is 71.9% below this benchmark. Historically, Genertec Universal Medical Group Co's own Cyclically Adjusted PS Ratio has ranged from 0.81 to 1.36 over the past decade. While the company's 10-year median is 1.09 vs. the industry median of 3.03, Genertec Universal Medical Group Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted PS Ratio for a Credit Services company?
The median Cyclically Adjusted PS Ratio among Credit Services companies is 3.03, based on 420 companies in the industry. Companies in the top quartile (top 25%) have a Cyclically Adjusted PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, Cyclically Adjusted PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Genertec Universal Medical Group Co's current Cyclically Adjusted PS Ratio of 0.85 is 71.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted PS Ratio mean?
A high Cyclically Adjusted PS Ratio can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted PS Ratio is the ratio of share price to a company's inflation-adjusted revenue per share over a 10-year period. View historical data on Genertec Universal Medical Group Co and its competitors. For the Credit Services industry, the median Cyclically Adjusted PS Ratio is 3.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Genertec Universal Medical Group Co's current Cyclically Adjusted PS Ratio is 0.85, which is 22% below median its own 10-year median of 1.09. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Genertec Universal Medical Group Co stock overvalued right now?
Based on GuruFocus' analysis, Genertec Universal Medical Group Co (FRA:5UM) is currently considered Fairly Valued. The stock's GF Value™ is €0.48, compared to a current price of €0.48 — trading 0.4% above its estimated fair value. The current Cyclically Adjusted PS Ratio is 0.85, which is 22% below median its 10-year median of 1.09 and 71.9% below the Credit Services industry median of 3.03. Genertec Universal Medical Group Co's overall GF Score™ is 48/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted PS Ratio calculated?
Cyclically Adjusted PS Ratio is calculated from a company's financial statements. For Genertec Universal Medical Group Co (FRA:5UM), the current Cyclically Adjusted PS Ratio is 0.85 as of Aug. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Genertec Universal Medical Group Co (FRA:5UM) Overvalued in 2026?
Based on GuruFocus' analysis, Genertec Universal Medical Group Co stock appears to be overvalued.
The current stock price of €0.48 is trading 0.4% above its estimated GF Value™ of €0.48.
GuruFocus considers Genertec Universal Medical Group Co to be Fairly Valued.
Key valuation signals for FRA:5UM:
Cyclically Adjusted PS Ratio: 0.85 (22% below median its 10-year median of 1.09)
GF Value™: €0.48 vs. price of €0.48 (0.4% above fair value)
Industry Position: 71.9% below the Credit Services median (#79 of 420)
No single metric tells the full story. See the FRA:5UM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Genertec Universal Medical Group Co Ltd is principally engaged in providing financing to its customers under finance lease arrangements, the provision of advisory services, the sale of medical equipment as well as leases under operating lease arrangements, and the provision of other services. The group has two business segments namely The finance business comprises direct finance leasing, sale-and-leaseback, factoring, operating leases, and advisory services; and Healthcare business comprises includes hospital group business, healthcare technology business and specialty business. Geographically, it derives a majority of its revenue from Mainland China.
48GF Score
Get the complete analysis for FRA:5UM
Cyclically Adjusted PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:5UM has been successfully added to your 
